Axogen Inc
Axogen Inc (AXGN) Covered Calls
Axogen Inc trades in the Medical Devices industry with an IV Rank of 47.62%, average versus the past year. AXGN's highest covered call setup is the $60.00 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 8.34% out of the money with 32 days to expiration, a 11.59% return until expiration, and a 132.23% theoretical annualized return. Across the setups shown, annualized returns run from 41.99% to 132.23% at strikes between $60.00 and $75.00, with 32 to 151 days to expiration, as of Nov 16, 2026.
Read more
Running AXGN covered calls helps you generate income from Axogen Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best AXGN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If AXGN stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling AXGN covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given AXGN covered call is worth writing.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments.
| 2026-12-18 | 32 | 60.00 | 8.34 | 1.80 | 2.30 | 642.00 | 11.59 | 132.23 | -3.25 | +0.36 | 79 | 0.50 |
| 2027-01-15 | 60 | 65.00 | 17.37 | 0.25 | 3.50 | 987.00 | 17.82 | 108.42 | -0.45 | +0.28 | 2 | 3.25 |
| 2027-04-16 | 151 | 75.00 | 35.43 | 1.75 | 4.00 | 2137.00 | 38.59 | 93.28 | -3.16 | +0.27 | 803 | 2.25 |
| 2027-04-16 | 151 | 70.00 | 26.40 | 2.35 | 5.60 | 1697.00 | 30.64 | 74.07 | -4.24 | +0.35 | 33 | 3.25 |
| 2027-01-15 | 60 | 60.00 | 8.34 | 1.95 | 4.60 | 657.00 | 11.86 | 72.17 | -3.52 | +0.41 | 31 | 2.65 |
| 2027-04-16 | 151 | 65.00 | 17.37 | 3.70 | 6.90 | 1332.00 | 24.05 | 58.14 | -6.68 | +0.42 | 203 | 3.20 |
| 2027-04-16 | 151 | 60.00 | 8.34 | 5.00 | 9.10 | 962.00 | 17.37 | 41.99 | -9.03 | +0.51 | 367 | 4.10 |
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV Rank47.62% Moderate
- Market cap (M$)3,307
- 52 weeks high-7.28%
- 52 weeks low140.74%
- Analyst recommendationStrong Buy
1.18 - Target price$59.27
7.04% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-10-28
- P/E—
- Future P/E78.47
- EPS (ttm)-0.65
- EPS growth next 5 years49.65%
As of Nov 17, 2026